JP2023511523A5 - - Google Patents

Info

Publication number
JP2023511523A5
JP2023511523A5 JP2022540697A JP2022540697A JP2023511523A5 JP 2023511523 A5 JP2023511523 A5 JP 2023511523A5 JP 2022540697 A JP2022540697 A JP 2022540697A JP 2022540697 A JP2022540697 A JP 2022540697A JP 2023511523 A5 JP2023511523 A5 JP 2023511523A5
Authority
JP
Japan
Prior art keywords
nucleic acid
lacto
genetically modified
seq
lnt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022540697A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023511523A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/051468 external-priority patent/WO2021148611A1/en
Publication of JP2023511523A publication Critical patent/JP2023511523A/ja
Publication of JP2023511523A5 publication Critical patent/JP2023511523A5/ja
Pending legal-status Critical Current

Links

JP2022540697A 2020-01-23 2021-01-22 Hmoの産生 Pending JP2023511523A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA202000087 2020-01-23
DKPA202000087 2020-01-23
PCT/EP2021/051468 WO2021148611A1 (en) 2020-01-23 2021-01-22 Hmo production

Publications (2)

Publication Number Publication Date
JP2023511523A JP2023511523A (ja) 2023-03-20
JP2023511523A5 true JP2023511523A5 (https=) 2023-09-21

Family

ID=74494875

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022540697A Pending JP2023511523A (ja) 2020-01-23 2021-01-22 Hmoの産生

Country Status (7)

Country Link
US (2) US12351806B2 (https=)
EP (2) EP4093878A1 (https=)
JP (1) JP2023511523A (https=)
CN (2) CN115003814A (https=)
AU (2) AU2021209395A1 (https=)
BR (1) BR112022014423A2 (https=)
WO (3) WO2021148620A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK180952B1 (en) * 2020-12-22 2022-08-10 Glycom As A dfl-producing strain
EP4281564A1 (en) 2021-01-22 2023-11-29 Glycom A/S New major facilitator superfamily (mfs) protein (fred) in production of sialylated hmos
DK181242B1 (en) * 2021-05-17 2023-05-30 Dsm Ip Assets Bv GENETICALLY ENGINEERED CELLS COMPRISING A RECOMBINANT NUCLEIC ACID SEQUNCE ENCODING AN α-1,2-FUCOSYLTRANSFERASE CAPABLE OF PRODUCING LNFP-I, NUCLEIC ACID SEQUENCES ENCODING SAME AND METHODS FOR USE OF SAME
DK181497B1 (en) * 2021-05-17 2024-03-12 Dsm Ip Assets Bv ENHANCING FORMATION OF THE HMOS LNT AND/OR LNnT BY MODIFYING LACTOSE IMPORT IN THE CELL
DK181991B1 (en) 2021-11-11 2025-05-15 Dsm Ip Assets Bv Combined fermentation process for producing one or more human milk oligosaccharide(s) (hmo(s)) in escherichia coli
CN118786221A (zh) 2022-03-02 2024-10-15 帝斯曼知识产权资产管理有限公司 用于体内合成3'sl和6'sl的新型唾液酸转移酶
DK181683B1 (en) * 2022-03-02 2024-09-20 Dsm Ip Assets Bv Cells exprssing new sialyltransferases for in vivo synthesis of lst-a, methods using same and constructs encoding said sialyltransferases
DK181319B1 (en) 2022-03-02 2023-08-10 Dsm Ip Assets Bv Genetically engineered cells and methods comprising use of a sialyltransferase for in vivo synthesis of 3’sl
EP4514989A1 (en) 2022-04-29 2025-03-05 DSM IP Assets B.V. Hmo producing microorganism with increased robustness towards glucose gradients
WO2023235555A1 (en) * 2022-06-02 2023-12-07 Bee-Io Honey Technologies Ltd. Cultured buffalo milk production methods, systems, compositions and uses thereof
DK181765B1 (en) 2022-07-15 2024-12-04 Dsm Ip Assets Bv Cells expressing new fucosyltransferases for in vivo synthesis of lnfp-iii, and methods and uses of same
EP4577061A1 (en) 2022-08-25 2025-07-02 DSM IP Assets B.V. Hybrid method for producing complex hmos
CN120265786A (zh) 2022-11-25 2025-07-04 帝斯曼知识产权资产管理有限公司 用于生产寡糖的双菌株系统
CN120677242A (zh) 2023-02-24 2025-09-19 帝斯曼知识产权资产管理有限公司 用于体内合成人乳寡糖的产物特异性转运蛋白
DK181822B1 (en) 2023-06-07 2025-01-30 Dsm Ip Assets Bv Genetically engineered strains with reduced byproduct formation and methods and uses of same
DK182227B1 (en) 2023-10-17 2025-12-18 Dsm Ip Assets Bv Genetically engineered cells comprising new fucosyltransferases for in vivo synthesis of complex fucosylated human milk oligosaccharides mixtures comprising lnfp-vi, methods using the same, and uses of new fucosyltransferases thereof.
DK202430472A1 (en) 2024-08-19 2026-02-24 Dsm Ip Assets Bv Alpha-1,2 fucosyltransferase mutants with increased alpha 1,3-fucosyltransferase activity

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7363028B2 (en) 2003-11-04 2008-04-22 Universal Electronics, Inc. System and method for controlling device location determination
DK2440661T3 (en) 2009-06-08 2018-03-12 Jennewein Biotechnologie Gmbh HMO synthesis
DE12746649T1 (de) 2011-02-16 2016-09-29 Glycosyn LLC Biosynthese menschlicher milcholigosaccaride in manipulierten Bakterien
EP2760875A4 (en) * 2011-09-30 2015-08-26 Glycom As SYNTHESIS OF HMO NUCLEAR STRUCTURES
PL2927316T3 (pl) * 2014-03-31 2019-05-31 Jennewein Biotechnologie Gmbh Całkowita fermentacja oligosacharydów
WO2015188834A1 (en) 2014-06-11 2015-12-17 Glycom A/S Separation of 2'-o-fucosyllactose from fermentation broth
AU2015315110B2 (en) 2014-09-09 2021-04-08 Glycosyn LLC Alpha (1,3) fucosyltransferases for use in the production of fucosylated oligosaccharides
DK3233875T3 (en) 2014-12-16 2022-12-19 Glycom As Separation of 2'-fl from a fermentation broth
EP3141610A1 (en) * 2015-09-12 2017-03-15 Jennewein Biotechnologie GmbH Production of human milk oligosaccharides in microbial hosts with engineered import / export
ES2991621T3 (es) 2016-03-07 2024-12-04 Glycom As Separación de oligosacáridos de caldo de fermentación
DK3445770T3 (da) 2016-04-19 2026-02-23 Glycom As Separering af oligosaccharider fra fermenteringssuppe
ES2856749T3 (es) * 2016-10-29 2021-09-28 Chr Hansen Hmo Gmbh Proceso para la producción de oligosacáridos fucosilados
CA3062242A1 (en) 2017-05-04 2018-11-08 Eaton Intelligent Power Limited Multi-dimensional location of an object using multiple electrical devices
CN111727253B (zh) 2017-12-21 2024-08-27 格礼卡姆股份公司 用于体外和体内基因表达的核酸构建体
US20190323052A1 (en) 2018-04-23 2019-10-24 Dupont Nutrition Biosciences Aps Increasing export of 2? fucosyllactose from microbial cells through the expression of a heterologous nucleic acid
WO2019209241A1 (en) * 2018-04-23 2019-10-31 Dupont Nutrition Biosciences Aps Increasing export of 2' fucosyllactose from microbial cells through the expression of a heterologous nucleic acid
US20190323053A1 (en) 2018-04-23 2019-10-24 Dupont Nutrition Biosciences Aps Increasing activity of 2? fucosyllactose transporters endogenous to microbial cells
EP3569713A1 (en) * 2018-05-16 2019-11-20 Jennewein Biotechnologie GmbH Use of glycosidases in the production of oligosaccharides
CN109609422A (zh) * 2018-11-20 2019-04-12 安徽天凯生物科技有限公司 一种可以产2’-岩藻基乳糖菌株的构建方法
US10519475B1 (en) 2018-11-21 2019-12-31 Amyris, Inc. Biosynthesis of compounds in yeast

Similar Documents

Publication Publication Date Title
JP2023511527A5 (https=)
JP2023511523A5 (https=)
JP2023511522A5 (https=)
JP2023511524A5 (https=)
CN115003687B (zh) Hmo生产
CN114981291B (zh) Hmo产生
JP2023511523A (ja) Hmoの産生
RU2013152648A (ru) Аденовирус обезьян и гибридные аденовирусные векторы
DK180952B1 (en) A dfl-producing strain
EP2714913A2 (en) Transcription terminator sequences
JP2013509168A5 (https=)
JP2022514761A5 (https=)
KR20250102136A (ko) 중추 신경계에서의 유전자 발현을 위한 핵산 조절 요소 및 사용 방법
CN109486814A (zh) 一种用于修复HBB1基因点突变的gRNA、基因编辑系统、表达载体和基因编辑试剂盒
CN106350541A (zh) 先天性免疫缺陷基因治疗载体构建方法及其用途
CN109536494A (zh) 一种用于修复HBB1基因点突变的gRNA、基因编辑系统、表达载体和基因编辑试剂盒
KR102633804B1 (ko) 재조합 바실러스 속 미생물 및 이를 이용한 모유올리고당 제조방법
CN103626851A (zh) 一种镉离子结合多肽及其编码序列
CN116042544A (zh) 一种血清型13型重组腺相关病毒及其制备方法和应用
CN117467704B (zh) 构建apod条件敲入小鼠模型的方法
CN104711240B (zh) 禽呼肠孤病毒σA蛋白及其相关生物材料的应用
CN103146753B (zh) 一种新的腺病毒载体及其生产方法
US20200061210A1 (en) Novel method for gene therapy using intranasal administration of genetically modified viral vectors
JP2024502257A (ja) 心筋細胞由来核酸調節エレメント並びにその方法及び使用
EP4093876A1 (en) New major facilitator superfamily (mfs) protein (fred) in hmo production